Department of Abdominal Surgery, University Hospital Leuven, Leuven, Belgium.
Surg Endosc. 2010 Feb;24(2):413-6. doi: 10.1007/s00464-009-0594-0. Epub 2009 Jun 25.
In the era of cost-conscious healthcare, hospitals are focusing on costs. Analysis of hospital costs per cost category may provide indications for potential cost-saving measures in the management of common bile duct stones (CBDS) with gallbladder in situ.
Between October 2005 and September 2006, 53 consecutive patients suffering from CBDS underwent either a one-stage procedure [laparoscopic common bile duct exploration (LCBDE) with stone clearance and cholecystectomy (LCCE)] or a two-stage procedure [endoscopic retrograde cholangiopancreatography with sphincterotomy and stone clearance (ERCP/ERS) followed by LCCE]. Costs were defined in different cost categories for each activity centre and were linked to the individual patient via the "bill of activities". Only patients (n = 38) with an uneventful post-procedural course and with available cost data were considered for cost analysis. Total length of hospital stay (LOS) was 2 (0-6) days after one-stage and 8 (3-18) days after two-stage procedure (p < 0.0001).
Costs per patient were significantly (p < 0.0001) less after one-stage versus two-stage management, i.e. total hospital costs (euro2,636 versus euro4,608), hospitalisation costs (euro701 versus euro2,190), consumables/pharmacy (euro645 versus euro1,476) and para-medical personnel (euro1,035 versus euro1,860; p = 0.0002). Operation room (OR) costs were comparable for one-stage and two-stage management (euro1,278 versus euro1,232; p = 0.280). Total hospital costs during ERCP were euro2,648 (euro729-4,544), during LCCE without LCBDE were euro2,101 (euro1,033-4,269), and during LCCE with LCBDE were euro2,636 (euro1,176-4,235).
In the management of patients with CBDS and gallbladder in situ a one-stage procedure is associated with significantly less costs as compared with a two-stage procedure. From the economical point of view these patients should preferably be treated via a one-stage procedure as long as safety and efficacy of this approach are provided.
在注重成本的医疗保健时代,医院关注的是成本。按成本类别分析医院成本,可能为管理原位胆囊胆总管结石(CBDS)提供潜在的节省成本措施的指示。
2005 年 10 月至 2006 年 9 月,53 例 CBDS 连续患者分别接受一期手术[腹腔镜胆总管探查术(LCBDE)+结石清除术+胆囊切除术(LCCE)]或二期手术[内镜逆行胰胆管造影术(ERCP)+括约肌切开术+结石清除术(ERCP/ERS)+LCCE]。每个活动中心都按不同的成本类别定义成本,并通过“活动账单”与每位患者相关联。只有无术后并发症且有可用成本数据的患者(n=38)被纳入成本分析。一期术后总住院时间(LOS)为 2(0-6)天,二期术后为 8(3-18)天(p<0.0001)。
与二期相比,一期治疗后患者的成本显著降低(p<0.0001),即总住院费用(欧元 2636 比欧元 4608)、住院费用(欧元 701 比欧元 2190)、消耗品/药房(欧元 645 比欧元 1476)和辅助医疗人员(欧元 1035 比欧元 1860;p=0.0002)。一期和二期的手术室(OR)成本相当(欧元 1278 比欧元 1232;p=0.280)。ERCP 期间的总住院费用为欧元 2648(欧元 729-4544),LCBDE 无 LCCE 期间为欧元 2101(欧元 1033-4269),LCBDE 期间为欧元 2636(欧元 1176-4235)。
在管理原位胆囊 CBDS 患者时,与二期相比,一期手术的成本显著降低。从经济角度来看,只要这种方法的安全性和有效性得到保证,这些患者最好通过一期手术进行治疗。